Thursday, June 25, 2020

Poseida Therapeutics Finds $110M More

San Diego-based biopharmaceuticals developer Poseida Therapeutics has raised $110M more in funding, in its Series D round, the company announced this morning. According to the company, the financing was led by led by funds advised by Fidelity Management Research Company, LLC, with participation by Adage Capital Management and Schonfeld Strategic Advisors, an

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.